CLINICAL_TRIALS
trial_result
· 2017-03-06
Clinical Trial Update: A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease [Phase 3]
Summary
A Phase III clinical trial evaluating nilvadipine for Alzheimer's disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Prof Brian Lawlor | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED